curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“There were also significant reductions in body mass index and serum levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, aspartate aminotransferase, alanine aminotransferase, glucose, and glycated hemoglobin compared with the placebo group.”
Quoted verbatim from Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- amorphous dispersion curcumin formulation 500 mg/day (~70 mg curcumin) for 8 weeks
- Population
- adults with ultrasound-diagnosed nonalcoholic fatty liver disease
Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.2016PMID:27270872Permalink
Keep reading
- Everything the graph holds on curcumin
- Every compound studied against Triglycerides
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M30XH0ATEA7N1QW2MJJD9KPP